Nipah virus: Will it be the next pandemic? Know everything about this zoonotic virus
New Delhi, Aug 10: Just as the world was learning to live with Covid-19, cringing at the nymph nodes occurring due to monkeypox, nature is introducing us to a new virus. Recently, China has found a new 'animal-derived' or zoonotic virus infecting humans in two of its provinces. The virus is called Langya Henipavirus (LayV). The new type of Henipavirus (also named Langya henipavirus, LayV) was found in throat swab samples from febrile patients in eastern China, state-run Global Times quoted media reports.
Currently, there is no vaccine or treatment for Henipavirus and the only treatment is supportive care to manage complications.
It should be noted that Langya Henipavirus belongs to the Nipah virus family and the WHO has listed the Nipah virus as the most likely virus to cause the next pandemic.
In India, Nipah virus outbreak in 2018 had killed 17 people of the 19 infected, a death rate of 89%. Kerala responded rapidly, and a health officer trained in Ebola outbreak protocols was brought in to ensure that the entire state isolated patients suspected of having Nipah. They also strengthened protocols for health workers wearing masks and for the decontamination of surfaces. Then in 2019, when Kerala saw another case in a young student, it deployed an extensive contact tracing system that was able to quickly test 329 people who had come into contact with the patient, preventing further spread. However, there were no deaths.
Nipah, a rare and often deadly disease which is back in the news with a student in Kerala diagnosed with the infection, is a zoonotic virus which means it is transmitted from animals such as bats or pigs to humans, and can also spread through contaminated food and people-to-people contact.
SIGNS AND SYMPTOMS:
Human infections range from asymptomatic (no symptoms) to acute respiratory infection and fatal encephalitis, involving inflammation of the brain, according to the World Health Organization (WHO). Infected people initially develop symptoms, including fever, headaches, myalgia (muscle pain), vomiting and sore throat. This can be followed by dizziness, drowsiness, altered consciousness, and neurological signs that indicate acute encephalitis. The incubation period -- interval from infection to the onset of symptoms -- mostly ranges from four to 14 days. Most people who survive acute encephalitis make a full recovery, but long term neurological conditions have been reported in survivors. The WHO estimates the case fatality rate at 40 per cent to 75 per cent.
During the first recognised outbreak in Malaysia, which also affected Singapore, most human infections resulted from direct contact with sick pigs or their contaminated tissues, according to WHO. Transmission is thought to have occurred via unprotected exposure to secretions from the pigs, or unprotected contact with the tissue of a sick animal. In subsequent outbreaks in Bangladesh and India, consumption of fruits or fruit products, such as raw date palm juice, contaminated with urine or saliva from infected fruit bats was the most likely source of infection. There are currently no studies on viral persistence in bodily fluids or the environment. Human-to-human transmission of the virus has also been reported among family and care givers of infected patients.
During later outbreaks in Bangladesh and India, the Nipah virus spread directly from human-to-human through close contact with people's secretions and excretions.
"Once humans consume it, the virus transfers to their body. So, the virus never went anywhere in the first place. This is just a case of seasonal reactivation," explained Dr P Venkata Krishnan, Internal Medicine, Paras Hospital, Gurgaon.
"Avoid travelling to those areas where the Nipah virus has been detected. The cases are localised to particular areas and are not widespread," he told PTI. Unlike swine flu, its transmission rate is very low, Krishnan said.
Initial signs and symptoms of the Nipah virus infection are nonspecific, and the diagnosis is often not suspected at the time of presentation. This can hinder accurate diagnosis and create challenges in outbreak detection, effective and timely infection control measures, and outbreak response activities. The main tests used are real time polymerase chain reaction (RT-PCR) from bodily fluids and antibody detection via enzyme-linked immunosorbent assay (ELISA). Other tests used include polymerase chain reaction (PCR) assay, and virus isolation by cell culture.
There are currently no drugs or vaccines specific for the infection although WHO has identified the virus as a priority disease for the WHO Research and Development "There is no vaccine available for Nipah right now. Ribavirin, an antiviral, may have a role in reducing mortality among patients with encephalitis caused by Nipah virus disease," said Dr Deepak Verma Internal Medicine, Columbia Asia Hospital in Ghaziabad.
"Quarantining infected people and culling infected animals remain the first response. For healthcare professionals, following standard operation procedure and maintaining hygiene are the important steps to prevent human to human transmission',' said Verma. According to a recent study published in the journal Science Translational Medicine, an experimental Ebola drug, remdesivir, protected monkeys against Nipah infection. Intensive supportive care is recommended for treating severe respiratory and neurologic complications.
Fruit bats Fruit bats of the family Pteropodidae -- particularly species belonging to the Pteropus genus -- are the natural hosts for Nipah virus. Outbreaks of the Nipah virus in pigs and other domestic animals such as horses, goats, sheep, cats and dogs were first reported during the initial Malaysian outbreak in 1999.
If an outbreak is suspected, the animal premises should be quarantined immediately. Culling of infected animals -- with close supervision of burial or incineration of carcasses -- may be necessary to reduce the risk of transmission to people. Restricting or banning the movement of animals from infected farms to other areas can reduce the spread of the disease. In the absence of a vaccine, the only way to reduce or prevent infection in people is by raising awareness of the risk factors and educating people about the measures they can take to reduce exposure to the Nipah virus.